Hei Ming Lai

Institution
The Chinese University of Hong Kong

Country
Hong Kong

Field
Biomedical Sciences

Lai won the 2024 Croucher Tak Wah Mak Innovation Award for leading research in creating a 3D spatial multi-omics platform for clinical diagnostics and spatial biology research.

 

(Photo: The Chinese University of Hong Kong)

AWARDS
  • 2024 Croucher Tak Wah Mak Innovation Award

Related articles

Recognizing Scientific Excellence With The Asian Scientist 100

These early career scientists and veteran researchers of the Asian Scientist 100 are making waves in diverse sectors of academia and industry, shedding light on natural phenomena and developing new technologies for a better world.

2018 Edition Of The Asian Scientist 100 List Announced

Asia is a hotbed for cutting-edge research, and these scientists of the Asian Scientist 100 are making waves in the region and around the world.

Asia’s Rising Scientists: Xue Shifeng

Using frogs and fish as model organisms, Dr. Xue Shifeng is shedding light on some of the most fundamental processes in developmental biology.

Indonesia’s Deadly 2018 Quake Was A Rare Supershear

Scientists in the US have identified the Palu earthquake in Indonesia as a supershear, a particularly destructive form of seismic movement.

Malaria Parasites May Skew Sex Ratio To Survive

Plasmodium vivax parasites alter their sex ratios in response to treatment with chloroquine, study shows.

Asia’s Rising Scientists: Benjamin Tee

Benjamin Tee develops electronic skin which can sense mechanical forces and self-heal repeatably—particularly useful for robotics and prosthetics.

Microfluidic Fabrication Made Simple

Scientists in Singapore have used fluoropolymers to create microfluidic devices that do not swell upon exposure to organic solvents.

Asia’s Scientific Trailblazers: Eugene Fitzgerald

Newly-appointed CEO of the Singapore-MIT Alliance for Research and Technology Professor Eugene Fitzgerald lists his priorities for the R&D center.

Teasing Out The Three Subtypes Of Liver Cancer

By combining genomic data with information about patients’ immunological status, scientists in Japan can now better characterize hepatocellular carcinoma.